223 related articles for article (PubMed ID: 9700474)
41. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
Beck-Peccoz P; Bassetti M; Spada A; Medri G; Arosio M; Giannattasio G; Faglia G
J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443
[TBL] [Abstract][Full Text] [Related]
42. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
43. Studies of two thyrotrophin-secreting pituitary adenomas: evidence for dopamine receptor deficiency.
Bevan JS; Burke CW; Esiri MM; Adams CB; Ballabio M; Nissim M; Faglia G
Clin Endocrinol (Oxf); 1989 Jul; 31(1):59-70. PubMed ID: 2598481
[TBL] [Abstract][Full Text] [Related]
44. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
45. Silent pituitary macroadenoma co-secreting growth hormone and thyroid stimulating hormone.
Sen O; Ertorer ME; Aydin MV; Erdogan B; Altinors N; Zorludemir S; Guvener N
J Clin Neurosci; 2005 Apr; 12(3):318-20. PubMed ID: 15851094
[TBL] [Abstract][Full Text] [Related]
46. Thyrotropin-producing microadenoma associated with pituitary resistance to thyroid hormone.
Watanabe K; Kameya T; Yamauchi A; Yamamoto N; Kuwayama A; Takei I; Maruyama H; Saruta T
J Clin Endocrinol Metab; 1993 Apr; 76(4):1025-30. PubMed ID: 8473377
[TBL] [Abstract][Full Text] [Related]
47. Adenoma of the human pituitary producing growth hormone and thyrotropin. A histologic, immunocytologic and fine-structural study.
Kovacs K; Horvath E; Ezrin C; Weiss MH
Virchows Arch A Pathol Anat Histol; 1982; 395(1):59-68. PubMed ID: 7080435
[TBL] [Abstract][Full Text] [Related]
48. Pituitary macroadenoma secreting thyrotropin and growth hormone: remission of bihormonal hypersecretion in response to lanreotide therapy.
Shimon I; Nass D; Gross DJ
Pituitary; 2001 Sep; 4(4):265-9. PubMed ID: 12501978
[TBL] [Abstract][Full Text] [Related]
49. Cosecreting TSH/GH pituitary adenomas-an 8-year experience in a single tertiary center.
Li X; Lynch L; Xing H; Wang Z; Zhu J; Deng K; Wang R; Yao Y; Lian X
Pituitary; 2020 Oct; 23(5):573-581. PubMed ID: 32681450
[TBL] [Abstract][Full Text] [Related]
50. Pathology of acromegaly.
Horvath E; Kovacs K
Neuroendocrinology; 2006; 83(3-4):161-5. PubMed ID: 17047379
[TBL] [Abstract][Full Text] [Related]
51. Clinical characteristics of patients with thyrotropin-secreting pituitary adenoma.
Wu YY; Chang HY; Lin JD; Chen KW; Huang YY; Jung SM
J Formos Med Assoc; 2003 Mar; 102(3):164-71. PubMed ID: 12783133
[TBL] [Abstract][Full Text] [Related]
52. Thyrotropin-releasing hormone (TRH) binding sites and thyrotropin response to TRH are regulated by thyroid hormones in human thyrotropic adenomas.
Le Dafniet M; Brandi AM; Kujas M; Chanson P; Peillon F
Eur J Endocrinol; 1994 Jun; 130(6):559-64. PubMed ID: 8205254
[TBL] [Abstract][Full Text] [Related]
53. Serum alpha-subunit levels in patients with pituitary adenomas.
Samejima N; Yamada S; Takada K; Sano T; Ozawa Y; Shimizu T; Usui M; Shishiba Y
Clin Endocrinol (Oxf); 2001 Apr; 54(4):479-84. PubMed ID: 11318783
[TBL] [Abstract][Full Text] [Related]
54. Free alpha-subunit and intact TSH secretion in vitro are closely associated in human somatotroph adenomas.
Aylwin SJ; King A; Blenke A; Geddes JF; Wood DF; Monson JP; Burrin JM
Eur J Endocrinol; 1998 Oct; 139(4):378-86. PubMed ID: 9820613
[TBL] [Abstract][Full Text] [Related]
55. Differential response to aminergic stimuli and biological behavior of growth hormone secreting pituitary adenomas.
Fanghanel G; Larraza O; Villalobos M; Fanghanel L; Velasco M; Velasco F
Can J Neurol Sci; 1990 Feb; 17(1):78-82. PubMed ID: 2107017
[TBL] [Abstract][Full Text] [Related]
56. Paradoxical response of thyrotropin to L-dopa and presence of dopaminergic receptors in a thyrotropin-secreting pituitary adenoma.
Chanson P; Orgiazzi J; Derome PJ; Bression D; Jedynak CP; Trouillas J; Legentil P; Racadot J; Peillon F
J Clin Endocrinol Metab; 1984 Sep; 59(3):542-6. PubMed ID: 6430950
[TBL] [Abstract][Full Text] [Related]
57. Response of a GH- and TSH-secreting pituitary adenoma to a somatostatin analogue (SMS 201-995): evidence that GH and TSH coexist in the same cell and secretory granules.
Malarkey WB; Kovacs K; O'Dorisio TM
Neuroendocrinology; 1989 Mar; 49(3):267-74. PubMed ID: 2716953
[TBL] [Abstract][Full Text] [Related]
58. The influence of diabetes mellitus on thyrotropin response to thyrotropin-releasing hormone in untreated acromegalic patients.
Shigemasa C; Abe K; Taniguchi S; Mitani Y; Ueta Y; Adachi T; Urabe K; Tanaka T; Yoshida A; Hori T
J Endocrinol Invest; 1988 Apr; 11(4):231-7. PubMed ID: 3137252
[TBL] [Abstract][Full Text] [Related]
59. Acute and chronic effects of octreotide on thyroid axis in growth hormone-secreting and clinically non-functioning pituitary adenomas.
Colao A; Merola B; Ferone D; Marzullo P; Cerbone G; Longobardi S; Di Somma C; Lombardi G
Eur J Endocrinol; 1995 Aug; 133(2):189-94. PubMed ID: 7655643
[TBL] [Abstract][Full Text] [Related]
60. Hormonal control of thyrotropin and growth hormone secretion in a human thyrotrope pituitary adenoma studied in vitro.
Simard M; Mirell CJ; Pekary AE; Drexler J; Kovacs K; Hershman JM
Acta Endocrinol (Copenh); 1988 Oct; 119(2):283-90. PubMed ID: 3176817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
